Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes.
Maahs, D, Alonso, G.T, Gallagher, M.P, Ebekozien, O We commend Gregory and colleagues for their well-designed prospective study to quantify…
Race/Ethnicity Disparities of presenting symptoms and outcomes among patients with type 1 diabetes with confirmed or suspected COVID-19 in the United States.
Gallagher, M.P, Noor, N, Odugbesan, O, Rioles, N, Alonso, T, Ebekozien, O Introduction: While there is rapidly emerging information describing race…
Diabetic ketoacidosis drives COVID-19 related hospitalizations in children with type 1 diabetes.
Alonso, G.T, Ebekozien, O, Gallagher, M.P, Rompicherla, S, Lyons, S, Choudhary, A, Majidi, S, Pinnaro, C, Balachandar, S, Gangat, M,…
Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID-19: Data from a multi-site surveillance registry.
Beliard, K, Ebekozien, O, Demeterco-Berggren, C, Alonso, T, Gallagher, M, Clements, M, Rapaport, R The severe acute respiratory syndrome coronavirus…
Equitable Post-COVID-19 Care: A Practical Framework to Integrate Health Equity in Diabetes Management
Ebekozien, O, Odugbesan, O, Rioles, N, Majidi, S, Yayah Jones, N-H, Kamboj, M Health equity has been described as the…
COVID-19 Hospitalization in Adults with Type 1 Diabetes: Results from the T1D Exchange Multi-Center Surveillance Study.
O’Malley, G, Ebekozien, O, Desimone, M, Pinnaro, C, Roberts, A, Polsky, S, Noor, N, Aleppo, G, Basina, M, Tansey, M,…
Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S
Ebekozien, O, Noor, N, Gallagher, M, Alonso, T. The Centers for Disease Control and Prevention states that individuals with diabetes…
